Rosetta Genomics (ROSG) plans to offer up to $35M in ordinary shares as the molecular...
Tuesday, June 26, 2012, 9:28 AM ETRosetta Genomics (ROSG) plans to offer up to $35M in ordinary shares as the molecular diagnostics firm looks to raise money for its operations and other purposes. Also, the state of New York approved ROSG's miRview lung assay for testing on patient samples; New York is the only U.S. state requiring an independent regulatory review process for lab tests.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles